We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




HIV Replication Suppressed by Measles

By Biotechdaily staff writers
Posted on 24 May 2002
A study has revealed that replication of HIV is mysteriously suppressed in patients with acute measles. More...
The study was published in the April 2002 issue of The Journal of Infectious Diseases.

In the study, researchers from the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) found that the HIV levels in HIV-infected children in Zambia with measles were significantly lower than in HIV-infected children who did not have measles. The HIV levels were measured when the children were admitted to the hospital for measles treatment, when they were discharged, and again one month later. They were compared with the levels in HIV-infected children who did not have measles.

The researchers found that 33 of the 93 children diagnosed with measles and HIV had a median HIV level of 5,339 copies per ml when they entered the hospital. These levels increased to 60,121 copies per ml when measured at discharge and to 387,148 copies per ml one month later. HIV-infected children who did not have measles had a median HIV level of 228,454 copies per ml. The researchers also found that the CD8 T cell level, an indicator of immune system response, was elevated in the children with both measles and HIV, compared to children in the control group.

"More research will be needed with a larger study group to fully understand how measles suppresses HIV and activates the immune system, but our findings may provide clues to understanding both HIV pathogenesis and immunity,” said Dr. Diane Griffin, professor, department of molecular microbiology and immunology at Johns Hopkins.





Related Links:
Johns Hopkins

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.